Hot Investor Mandate 4: Midwest-Focused VC Invests Early in Therapeutics, Diagnostics, Med Devices, and HCIT

29 Jun

A healthcare-focused venture capital firm with two offices in the Midqest has over $200 million in assets under management, and is currently investing out of its fifth fund. The firm makes seed and early-stage investments in healthcare companies, with typical initial investment sizes ranging from $250k to $2 million, and total investment up to $8 million over the life cycle of a company. The firm focuses on Midwest opportunities, and leverages its national network of syndicate and strategic partners to capitalize on ideas and funds from outside the region.

The firm is looking for new investment opportunities in the therapeutic, diagnostic, medical device and healthcare IT sectors. The firm focuses on technology in preclinical to clinical phases of development. The firm invests in products that offer a distinct and sustainable competitive advantage in the marketplace.

The firm invests in private companies with experienced and committed management teams. Companies should have the growth potential to exit in a five to seven-year period.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: